Strategy

Biotech’s Next Frontier | Ep. 703

Creating the Next Mega-Blockbusters Market Opportunities

Jun 15

From Beams to Bullets | Ep. 696

The Radiotherapy Renaissance

Jun 8

Pan-Tumor is the Future | Ep. 689

Building Precision with Optionality

Jun 1

The Oral Peptide Revolution | Ep. 683

From Insulin to 2025 and Beyond

May 25

Biotech Salaries Are Rising | Ep. 676

But the Picture Isn’t All Rosy

May 18

The IRA’s Silent Kill Switch | Ep. 669

How a 9-Year Price Control Is Gutting Biotech’s Future

May 11

Venture Capital’s Game of Inches | Ep. 662

Strategies, Predictions, and Theories That Matter

May 4 •

The Future of Immuno-Oncology | Ep. 655

What Comes After Checkpoints?

Apr 27

Rethinking Biotech Venture Strategy | Ep. 648

Is the Power Law Broken?

Apr 20 •

Who Owns the Right to Rewrite DNA? | Ep. 641

Defining the Future of DNA

Apr 13 •

The DEI Pendulum in Biotech | Ep. 634

Have We Gone Too Far?

Apr 6 •

Building Differentiated ADC Programs | Ep. 627

Novel Target, Linker, and Payload Technologies

Mar 30 •

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts